No clinical relevance of cytokeratin positive cells in bone marrow of patients with primary breast cancer

被引:0
|
作者
Kaul, S. [1 ]
Sonnauer, M. [1 ]
Bartik, B. [1 ]
Zeifang, F. [2 ]
Bastert, G.
Fersis, N. [3 ]
机构
[1] Univ Frauenklin Heidelberg, Heidelberg, Germany
[2] Orthopad Klin Schlierbach, Heidelberg, Germany
[3] Klinikum Chemnitz, Chemnitz, Germany
关键词
disseminated tumor cells; standard immunocytology;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:S11 / S11
页数:1
相关论文
共 50 条
  • [41] Clinical importance of the detection of isolated tumor cells in bone marrow and peripheral blood in patients with primary breast cancer
    Janni, W.
    Fehm, T.
    Rack, B.
    Mueller, V.
    Solomayer, E.
    Stickeler, E.
    Sommer, H.
    Schindlbeck, C.
    Jueckstock, J.
    Friese, K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (06) : 653 - 660
  • [42] Prognostic Relevance of Disseminated Tumor Cells in the Bone Marrow of Patients with Primary Breast Cancer - Results of a Standardized Follow-Up
    Schindlbeck, C.
    Pfab, G.
    Jueckstock, J.
    Andergassen, U.
    Sommer, H.
    Janni, W.
    Friese, K.
    Rack, B.
    ANTICANCER RESEARCH, 2011, 31 (09) : 2749 - 2755
  • [43] Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
    Schardt, JA
    Meyer, M
    Hartmann, CH
    Schubert, F
    Schmidt-Kittler, O
    Fuhrmann, C
    Polzer, B
    Petronio, M
    Eils, R
    Klein, CA
    CANCER CELL, 2005, 8 (03) : 227 - 239
  • [44] Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN
    Wollenberg, B
    Walz, A
    Kolbow, K
    Pauli, C
    Chaubal, S
    Andratschke, M
    ONKOLOGIE, 2004, 27 (04): : 358 - 362
  • [45] Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients
    Coombes, RC
    De Bella, MT
    Tripuraneni, G
    Zaidi, A
    Anwer, S
    Stephens, DA
    Ward, B
    Sinnett, HD
    Slade, MJ
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 1) : S5 - S6
  • [46] Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients
    RC Coombes
    MT De Bella
    G Tripuraneni
    A Zaidi
    S Anwer
    DA Stephens
    B Ward
    HD Sinnett
    MJ Slade
    Breast Cancer Research, 7
  • [47] Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. (vol 342, pg 525, 2000)
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04): : 308 - +
  • [48] Factors Associated with Positive Bone Marrow Biopsy in Patients with Breast Cancer
    Mascaro, A.
    Vitelli, C. E.
    Baldi, A.
    Farina, M.
    Amini, M.
    Piro, F.
    Fortunato, L.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 50 - 50
  • [49] Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
    Effenberger, Katharina E.
    Borgen, Elin
    Eulenburg, Christine Zu
    Bartkowiak, Kai
    Grosser, Andrea
    Synnestvedt, Marit
    Kaaresen, Rolf
    Brandt, Burkhard
    Nesland, Jahn M.
    Pantel, Klaus
    Naume, Bjorn
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) : 729 - 738
  • [50] Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
    Katharina E. Effenberger
    Elin Borgen
    Christine zu Eulenburg
    Kai Bartkowiak
    Andrea Grosser
    Marit Synnestvedt
    Rolf Kaaresen
    Burkhard Brandt
    Jahn M. Nesland
    Klaus Pantel
    Bjorn Naume
    Breast Cancer Research and Treatment, 2011, 125 : 729 - 738